Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tcl1 as a model for lymphomagenesis.

Yuri Pekarsky1, Nicola Zanesi, Rami Aqeilan

  • 1Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, BLSB 1050, Philadelphia, PA 19107, USA.

Hematology/Oncology Clinics of North America
|August 25, 2004
PubMed
Summary

This article explores the molecular drivers behind mature T-cell leukemia and chronic lymphocytic leukemia, two significant lymphoproliferative neoplasms. Understanding these mechanisms is key to developing targeted therapies for these mature lymphoid malignancies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutation of TGFβ-RII eliminates NSAID cancer chemoprevention.

Oncotarget·2018
Same author

Loss of miR-204 expression is a key event in melanoma.

Molecular cancer·2018
Same author

Retraction for Melillo et al., "Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation".

Molecular and cellular biology·2018
Same author

Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia.

Oncotarget·2018
Same author

Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis.

Cancer letters·2018
Same author

The role of MicroRNAs in human cancer.

Signal transduction and targeted therapy·2017

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Mature leukemias and lymphomas are cancers of mature lymphocytes.
  • These conditions involve the abnormal accumulation of lymphocytes in various tissues.
  • They represent a diverse group of lymphoproliferative neoplasms.

Purpose of the Study:

  • To elucidate the molecular pathogenesis of mature T-cell leukemia.
  • To investigate the molecular pathogenesis of chronic lymphocytic leukemia.
  • To provide insights into the molecular mechanisms driving these mature lymphoid malignancies.

Main Methods:

  • Review of current literature on molecular mechanisms.
  • Analysis of pathogenetic pathways in mature T-cell leukemia.
  • Analysis of pathogenetic pathways in chronic lymphocytic leukemia.

Related Experiment Videos

Main Results:

  • Detailed discussion of molecular alterations in mature T-cell leukemia.
  • Detailed discussion of molecular alterations in chronic lymphocytic leukemia.
  • Identification of key molecular pathways contributing to lymphoproliferation.

Conclusions:

  • Molecular mechanisms are critical in the development of mature leukemias and lymphomas.
  • Understanding these mechanisms can inform future therapeutic strategies.
  • Further research into specific molecular targets is warranted.